TeleBlut - individual early recognition of anaemia and polycythemia in the northern Saxony-Anhalt

• Conditions: D64.9; F32.9; D45; Anaemia, unspecified; Depressive episode, unspecified; Polycythaemia vera

• Registration Number: DRKS00010882
• Lead Sponsor: niversitätsklinikum Magdeburg A.ö.R.Universitätsklinik für Hämatologie und Onkologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 3058

Inclusion Criteria

1. Resident of the administrative districts of the northern Saxony-Anhalt
2. Age 50 years and older
3. signed study consent

Exclusion Criteria

1. Age under 50 years
2. Principal residence outside the selected administrative districts of the northern Saxony-Anhalt
3. Out- or inpatient treatment in the last 2 weeks prior to study inclusion

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
a) Registration of incidence of anemia and polycythemias (polycythemia vera, essential thrombocytemia, primary myelofibrosis) for 50+ aged residents of the administrative districts of the northern Saxony-Anhalt by applying the following laboratory parameters: leucocytes, erythrocytes, haemoglobin, hematocrit, mean cell volume, mean cell hemoglobin, mean cell hemoglobin concentration, platelets and differential leucocyte count<br><br>b) Aspects of health-related quality of life and depressive symptoms were assessed with SF-12 (medical outcomes study-12 Short Form Health Survey), Patient Health Questionnaire (PHQ-9), and an medical interview about lifetime and 12-month prevalence for major depression.

Secondary Outcome Measures

Name	Time	Method
Incidence of the JAK2, MPL and calreticulin mutations particularly in healthy test persons<br>as well as incidence of lack of vitamin B12, folic acid and iron.